Bocci, Guido
Kerbel, Robert S.
Article History
First Online: 17 May 2016
Competing interests
: R.S.K. is a Scientific Advisory Board member of Angiocrine Biosciences, Eli Lilly, and MolMed; is a consultant to Cerulean Pharma, Merrimack Pharmaceuticals, and Triphase Accelerator; and holds stock from Angiocrine Biosciences. Over the past 2 years, R.S.K. has received honoraria from Boehringer-Ingelheim, Eli Lilly, Oncology Education, NED Biosciences and Regeneron. G.B. declares no competing interests.